Eco R1 Capital, LLC Denali Therapeutics Inc. Transaction History

Eco R1 Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$23.13 - $38.84 $17 Million - $28.5 Million	-733,561 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$16.01 - $28.82 $567,714 - $1.02 Million	35,460 Added 5.08%	733,561 $17.7 Million
Q1 2020 May 15, 2020	BUY	$14.2 - $27.98 $9.91 Million - $19.5 Million	698,101 New	698,101 $12.2 Million
Q2 2018 Aug 14, 2018	SELL	$15.25 - $21.02 $4.96 Million - $6.83 Million	-325,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$15.36 - $24.8 $1.92 Million - $3.1 Million	125,000 Added 62.5%	325,000 $6.4 Million
Q4 2017 Feb 14, 2018	BUY	$15.04 - $21.45 $3.01 Million - $4.29 Million	200,000	200,000 $3.13 Million

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.